{"acquisitions":[],"changes":[],"country":"CH","description":"Alp Bio runs immunogenicity assessment for therapeutic antibodies using tonsil-organoid technology plus protein AI. It serves biopharma teams developing monoclonals. Differentiator: human ex-vivo immune readouts fused with ML to predict anti-drug antibody formation early.","domain":"alp.bio","employees":null,"founded":2025,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":47.396515,"lng":8.444486,"location":"Schlieren, CH","multiples":[],"name":"ALP Bio","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2052000,"connectionsAmong":[],"currency":"EUR","date":"2026-04-30","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"alp-bio-2026-04-30-pre-seed","source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-06","status":"attributed","url":null},"status":"attributed","type":"pre-seed","url":null}],"slug":"alp-bio","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-06","status":"attributed","url":null},{"fact":"existence","publisher":"alp.bio","retrievedAt":"2026-05-06","status":"self-reported","url":"https://alp.bio"},{"fact":"description","publisher":"alp.bio","retrievedAt":"2026-05-06","status":"self-reported","url":"https://alp.bio"}],"stage":"pre-seed","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["LiteSpeed","PHP 8.3.30","WordPress 6.9.4","Moment.js","Hostinger","HubSpot","WordPress Block Editor","WordPress Site Editor","React","MySQL"],"totalRaisedUsd":2052000,"traction":[],"updatedAt":"2026-05-06","valuations":[]}